Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

Published:1997-10 Issue:10 Volume:4 Page:796-801
ISSN:1072-8368
Container-title:Nature Structural Biology
language:
Short-container-title:Nat Struct Mol Biol

Author:

Lawrie Alison M.,Noble Martin E.M.,Tunnah Paul,Brown Nicholas R.,Johnson Louise N.,Endicott Jane A.

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biochemistry,Structural Biology

Reference41 articles.

1. Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinase

2. Different Susceptibility of Protein Kinases to Staurosporine Inhibition. Kinetic Studies and Molecular Bases for the Resistance of Protein Kinase CK2

3. Staurosporine, a Potentially Important Gift from a Microorganism.

4. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death.

5. G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637.

Cited by 262 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reporting multitargeted potency of Tiaprofenic acid against lung cancer: Molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies;International Journal of Biological Macromolecules;2024-09

2. Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity;Archiv der Pharmazie;2024-07-23

3. Computational Insights into Papaveroline as an In Silico Drug Candidate for Alzheimer’s Disease via Fyn Tyrosine Kinase Inhibition;Molecular Biotechnology;2024-07-14

4. Unrevealing the multitargeted potency of 3-1-BCMIYPPA against lung cancer structural maintenance and suppression proteins through pharmacokinetics, QM-DFT, and multiscale MD simulation studies;PLOS ONE;2024-06-21

5. The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles;Pharmaceuticals;2024-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3